Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jahae Kim

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Nuclear Medicine and Molecular Imaging|August 14, 2018
Response Prediction of Altered Thyroglobulin Levels After Radioactive Iodine Therapy Aided by Recombinant Human Thyrotropin in Patients with Differentiated Thyroid CancerMinchul Song, Subin Jeon, Sae-Ryung Kang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEun Hyun Seo, Hyung-Jun Yoon, Seung Gon Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 21, 2011
Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancerJong-Ryool Oh, Byung-Hyun Byun, Sun-Pyo Hong, et al.
Nuclear Medicine and Molecular Imaging|December 21, 2016
Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid CarcinomaGeum-Cheol Jeong, Minchul Song, Hee Jeong Park, et al.
Nuclear Medicine Communications|May 20, 2020
Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinomaSubin Jeon, Seong Young Kwon, Young Jae Ryu, et al.
Nuclear Medicine and Molecular Imaging|June 7, 2021
Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid CarcinomaJang Bae Moon, Subin Jeon, Ki Seong Park, et al.
Nuclear Medicine and Molecular Imaging|August 25, 2020
Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary SiteSu Woong Yoo, Md Sunny Anam Chowdhury, Subin Jeon, et al.
Nuclear Medicine and Molecular Imaging|September 24, 2015
Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid CarcinomaHee Jeong Park, Geum-Cheol Jeong, Seong Young Kwon, et al.
Cancers|January 26, 2020
Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid CarcinomaSu Woong Yoo, Md Sunny Anam Chowdhury, Subin Jeon, et al.
Nuclear Medicine Communications|February 24, 2021
Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinomaSu Woong Yoo, Dong-Yeon Kim, Ayoung Pyo, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Nuclear Medicine and Molecular Imaging|August 14, 2018
Response Prediction of Altered Thyroglobulin Levels After Radioactive Iodine Therapy Aided by Recombinant Human Thyrotropin in Patients with Differentiated Thyroid CancerMinchul Song, Subin Jeon, Sae-Ryung Kang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEun Hyun Seo, Hyung-Jun Yoon, Seung Gon Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 21, 2011
Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancerJong-Ryool Oh, Byung-Hyun Byun, Sun-Pyo Hong, et al.
Nuclear Medicine and Molecular Imaging|December 21, 2016
Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid CarcinomaGeum-Cheol Jeong, Minchul Song, Hee Jeong Park, et al.
Nuclear Medicine Communications|May 20, 2020
Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinomaSubin Jeon, Seong Young Kwon, Young Jae Ryu, et al.
Nuclear Medicine and Molecular Imaging|June 7, 2021
Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid CarcinomaJang Bae Moon, Subin Jeon, Ki Seong Park, et al.
Nuclear Medicine and Molecular Imaging|August 25, 2020
Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary SiteSu Woong Yoo, Md Sunny Anam Chowdhury, Subin Jeon, et al.
Nuclear Medicine and Molecular Imaging|September 24, 2015
Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid CarcinomaHee Jeong Park, Geum-Cheol Jeong, Seong Young Kwon, et al.
Cancers|January 26, 2020
Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid CarcinomaSu Woong Yoo, Md Sunny Anam Chowdhury, Subin Jeon, et al.
Nuclear Medicine Communications|February 24, 2021
Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinomaSu Woong Yoo, Dong-Yeon Kim, Ayoung Pyo, et al.
Pageof 8